Panagiotou Marios, Church Alistair C, Johnson Martin K, Peacock Andrew J
Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK.
Eur Respir Rev. 2017 Jan 17;26(143). doi: 10.1183/16000617.0053-2016. Print 2017 Jan.
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of increased pulmonary vascular resistance, pre-capillary pulmonary hypertension and right heart failure in interstitial lung disease, and provides guidance on its management.
肺血管和心脏损害日益被视为间质性肺疾病自然病程中的一个主要不利因素。这篇以临床为导向的综述聚焦于间质性肺疾病中肺血管阻力增加、毛细血管前肺动脉高压和右心衰竭这一有害序列的发病机制、病理生理学及影响方面的当前概念,并为其管理提供指导。